GlassScriptPhysician profile
Phillip K Stokes
NPI 1851778682
$4,353.17
in general payments reported to CMS, 2019-2025
34 companies · $1,790 in 2025
The $1,790 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $128 · 2021: $232 · 2022: $290 · 2023: $674 · 2024: $977 · 2025: $1,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,440.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $718.46 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, General - Female Sui |
| Accord Healthcare, INC. | $625.47 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $325.01 | 2022-2025 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $280.19 | 2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Olympus America INC. | $256.66 | 2019-2025 | Itind System |
| Pfizer INC. | $245.94 | 2023-2025 | |
| Abbvie INC. | $238.83 | 2022-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $229.09 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $217.62 | 2024-2025 | |
| Janssen Biotech, INC. | $195.14 | 2025 | Erleada, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $144.86 | 2022-2025 | |
| Axonics, INC. | $107.97 | 2023-2024 | Axonics, Bulkamid |
| Teleflex LLC | $82.30 | 2025 | Barrigel, Urolift |
| Rochester Medical Corporation | $75.94 | 2022 | |
| Endo Pharmaceuticals INC. | $74.67 | 2021-2023 | Aveed, Xiaflex |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $55.67 | 2023 | |
| Astellas Pharma US INC | $54.10 | 2022-2023 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $46.59 | 2025 | Prolaris |
| Agiliti Surgical, INC. | $46.42 | 2025 | Koelis Trinity Mri/US Fusion, Quanta System Fiber Dust Tfl Laser, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Photocure INC | $42.78 | 2024 | Cysview |
| Progenics Pharmaceuticals, INC. | $35.03 | 2023 | Pylarify |
| Blue Earth Diagnostics | $33.66 | 2022 | |
| Medline Industries LP | $31.99 | 2025 | |
| Ferring Pharmaceuticals INC. | $25.18 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $22.87 | 2022 | |
| Laborie Medical Technologies Corp. | $20.65 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2025 | |
| Angiodynamics, INC. | $15.11 | 2024 | Nanoknife |
| Ambu INC. | $15.08 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.99 | 2022 | |
| Antares Pharma, INC. | $14.84 | 2023 | Xyosted, Tlando, Nocdurna |
| Hollister Incorporated | $13.96 | 2023 | Vapro, Onli, Infyna Chic |
| Endo USA, INC. | $13.76 | 2025 | Xiaflex |
| Civco Medical Instruments | $13.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.